Diabetic macular edema (DME) is a complication of diabetic retinopathy. It occurs when fluid builds up in the macula, the center portion of the retina. The retina is the layer of cells at the back of ...

About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...

Ocugen said the Food and Drug Administration lifted a clinical hold on its OCU200 investigational treatment for diabetic macular edema, paving the way for Phase 1 trials.

especially diabetic macular edema, and due to proliferative diabetic retinopathy. Vision loss due to DR is preventable with the appropriate monitoring and timely treatment. Improved patient and ...

Microaneurysm size can be effectively reduced in patients with diabetic macular edema with anti-vascular endothelial growth factor therapy.

Screening for diabetic retinopathy remains a challenge for patient care organizations nationwide, particularly those that are ...

New AI-driven test identifies diabetic retinopathy risk, promising better care for patients in Israel and beyond.

Efferocytosis’ role in retinopathy is largely unknown despite knowledge of the process in other diseases.